RUNX2 and breast cancer: Notably, the expression levels of Wnt, β-catenin, RUNX2 and OCN in the LA@BC group were approximately 2.5-fold, 2-fold, 2.5-fold and 1.5-fold respectively higher than those in the Control group, indicating advanced osteoblast differentiation.